Xuejun Wen

Title: Innovations of Xuejun Wen in Dual-Targeting Compounds

Introduction

Xuejun Wen is a notable inventor based in Shandong, China. He has made significant contributions to the fields of nuclear medicine and molecular imaging. His work focuses on developing innovative compounds that enhance the targeting of tumors.

Latest Patents

Xuejun Wen holds 1 patent for a dual-targeting compound and its preparation method and application. This patent relates to a dual-targeting compound that exhibits high affinity for both FAP and integrin αβ targets in tumors. The compound is designed to improve the uptake and retention time in tumors, making it a promising candidate for diagnostic and therapeutic applications.

Career Highlights

Wen is associated with Yantai Lannacheng Biotechnology Co., Ltd., where he continues to advance his research in molecular imaging. His innovative approach to dual-targeting compounds has the potential to revolutionize treatment methods for diseases characterized by the overexpression of specific targets.

Collaborations

Xuejun Wen collaborates with notable colleagues, including Xiaoyuan Chen and Pengfei Xu. Their combined expertise contributes to the advancement of research in the field of biotechnology.

Conclusion

Xuejun Wen's work in developing dual-targeting compounds represents a significant advancement in nuclear medicine and molecular imaging. His innovative contributions are paving the way for improved diagnostic and therapeutic strategies in oncology.